Courier Capital’s Cadrenal Therapeutics CVKD Stock Holding History

Courier Capital’s Portfolio CVKD Stock Details CVKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.4K	Buy	+19,837	New	+$36K	﹤0.01%	403

Other funds holding CVKD

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Courier Capital's CVKD Position: Q3 2026 in Review

Courier Capital opened a new position in Cadrenal Therapeutics (CVKD) in Q3 2026: 19,837 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #403 among its holdings.

5 funds tracked by Wall St. Rank hold CVKD as of Q3 2026.

Courier Capital held 19,837 shares of Cadrenal Therapeutics worth $21.4K as of Q3 2026.
Cadrenal Therapeutics was a new Courier Capital position in Q3 2026.
Cadrenal Therapeutics made up ﹤0.01% of Courier Capital's portfolio in Q3 2026, its #403 holding.
5 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q3 2026.

Based on Courier Capital's 13F filing for Q3 2026, filed 13 Oct 2026.